Xconomy National

Archives

by in

Entry	Author	Date	Location
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting	Luke Timmerman	01/23/12	National
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership	Luke Timmerman	01/17/12	San Francisco
Merck Chemists Use High-Tech Science to Combat Alzheimer’s Disease Challenge	Arlene Weintraub	12/14/11	New York
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1)	Luke Timmerman	11/21/11	National
UW Spinoff Impel NeuroPharma Nabs Two Big Pharma Deals, $500K in Angel Financing	Luke Timmerman	10/20/11	Seattle
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum	Arlene Weintraub	09/29/11	New York
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s	Arlene Weintraub	07/25/11	Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs	Luke Timmerman	05/25/11	Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma	Luke Timmerman	05/24/11	San Francisco
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives	Luke Timmerman	05/13/11	San Francisco
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting	Richard Watson	04/14/11	Seattle
Medivation, Pfizer Fail Huntington’s Test	Luke Timmerman	04/11/11	San Francisco
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders	Gregory T. Huang	03/01/11	Boston
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News	Bruce V. Bigelow	01/20/11	San Diego
Sanford-Burnham Strikes Deal With J&J, Second Big Pharma Alliance in a Month	Luke Timmerman	01/17/11	San Diego
Neuroptix Raises $4.6M	Erin Kutz	01/07/11	Boston
Allon Starts Trial for Brain Disease	Luke Timmerman	01/06/11	Seattle
$7M for Satori Pharmaceuticals	Ryan McBride	01/04/11	Boston
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M	Ryan McBride	12/21/10	Boston
Fighting Alzheimer’s: New Hope in a New Year Through Innovation	Steve Runnels	12/20/10	Seattle
Uncle Sam Delivers $18.4M in Research Awards to Michigan Biotechs	Ryan McBride	11/05/10	Detroit
Allon Therapeutics Adds $10M	Luke Timmerman	11/01/10	Seattle
iPierian Nabs $28M, With New Backing From Glaxo and Biogen Idec, To Use Stem Cells for Drug Discovery	Luke Timmerman	09/08/10	San Francisco
It’s Time for Universities to Get More Nimble	Regis Kelly	09/02/10	San Francisco
Taking a VC Approach to Charity, Greylock Veteran’s Alzheimer’s Research Foundation “Dares to Be Great”	Erin Kutz	08/25/10	Boston
Montgomery Says Goodbye Gilead, Kaleetan’s Plan to Be the Next Dendreon, Calypso’s CEO Exit, & More Seattle-Area Life Sciences News	Luke Timmerman	08/12/10	Seattle
Alectos Snags Merck Deal	Luke Timmerman	08/11/10	Seattle
BrainCells Inc. Buys Neuro Drug	Luke Timmerman	08/04/10	San Diego
Immune Design Pockets $32M, InDi Nails $10M, SonoSite Looks Inside My Carotids, & More Seattle-Area Life Sciences News	Luke Timmerman	07/29/10	Seattle
Page 1 of 3	next page »